Leukaemia Care and Lymphoma Action - CLL t... - Leukaemia CARE

Leukaemia CARE

989 members588 posts

Leukaemia Care and Lymphoma Action - CLL treatment update webinars – 26th April and 5th May 2021

HAIRBEAR_UK profile image
HAIRBEAR_UKAdministrator

It has been a good start to the year with several new CLL treatments being approved or approaching approval in UK countries.

Leukaemia Care and Lymphoma Action are pleased to provide two joint CLL webinars to help with understanding the increasingly complex picture of CLL treatment and options for different groups. Please join us for these treatment update webinars as we chat to the experts and explore first line treatments and second line treatment for those who have relapsed or are refractory.

Webinar 1

Date: Monday 26th April 2021

Time: 3:30pm

Topic: CLL first-line treatments

Host: Leukaemia Care and Lymphoma Action

This webinar will update on CLL first treatments today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

We will be joined by:

•Dr George Follows, Consultant Haematologist at Cambridge University Hospitals Trust and Visiting Professor of Haematology, Anglia Ruskin Medical School Associate Lecturer, University of Cambridge

Dr Follow’s special interests are in chronic lymphocytic leukaemia (CLL) and lymphoma.

•Helen Knight, CLL-specific CNS at Nottingham University Hospitals

Helen Knight is one of just a handful of CLL-specific clinical nurse specialists across the UK.

• John Perkins and Liz Landers, CLL patients.

Register in advance here: us02web.zoom.us/webinar/reg...

Webinar 2

Date: Wednesday 5th May 2021

Time: 3:30pm

Topic: CLL second-line and subsequent treatments

Host: Leukaemia Care and Lymphoma Action

This webinar will update on CLL second-line treatments today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

We will be joined by:

•Dr Tahla Munir, Consultant in Clinical Haematology at Leeds Teaching Hospitals NHS Trust.

Dr Munir’s main clinical and research special interests are in chronic lymphocytic leukaemia, particularly in the assessment of the mechanism of action of novel targeted therapies.

• Lianne Palmer, CLL-specific CNS at Oxford University Hospitals.

Lianne Palmer is one of just a handful of CLL-specific clinical nurse specialists across the UK.

• Robin Edwards and Nick York, CLL patients.

Register in advance here: us02web.zoom.us/webinar/reg...

How do I join the webinar?

The webinar is being hosted on Zoom and Facebook, meaning you can choose a platform to suit you. Zoom is the best place to ask questions, but if you join via Facebook we will try and get all the questions sent over to our panel; however, please expect a delay.

Information on how to join via Zoom or Facebook is below.

Watch via Zoom

To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.

Watch via Facebook

To join via Facebook, all you need is a Facebook account. Once logged in head to Leukaemia Care's Facebook page at 3:30pm on 26th April and find the live video (it will be at the top of our feed).

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

Due to the large amount of registrants, we cannot guarantee that everyone's questions will be answered, but we will try and do our best in the time frame that we have.

If you have any issues registering via Zoom or issues on the day, please get in touch by emailing advocacy@leukaemiacare.org.uk.

Hope to see you there

Best wishes

Nick

3 Replies
2003UK profile image
2003UKChampion

Thanks Hairbear and Leukaemia Care for these 2 CLL great Zoom opportunities

HAIRBEAR_UK profile image
HAIRBEAR_UKAdministrator

Today NICE has released Final Guidance for acalabritinib access in England and Wales - Acalabrutinib for untreated and treated chronic lymphocytic leukaemia [ID1613] nice.org.uk/guidance/TA689

Starting a treatment is a big step to take in the CLL journey. The great news of several new treatments now available or about to become available in the UK, has added to the complexity of decision making with your care team.

These CLL specific treatment webinars aim to give patients confidence to become more involved in your healthcare discussions and treatment decisions with your care teams.

If treatment is on your radar, please join us and register free for a UK CLL treatments update webinar.

CLL first-line treatments update - 3.30pm BST 26th April us02web.zoom.us/webinar/reg...

And or a

CLL 2nd line and subsequent treatments update -3.30pm BST 5th May

us02web.zoom.us/webinar/reg...

If you have questions for the UK clinical experts please do let us know in advance by email at advocacy@leukaemiacare.org.uk or share them in the thread here.

Best wishes

Nick

HAIRBEAR_UK profile image
HAIRBEAR_UKAdministrator

It's not too late to register for this very current webinar hosted by Leukaemia Care and Lymphoma action to bring you up to date of latest 1st line CLL treatment in the UK.

Join us at 3.30pm BST today (Monday 26 April) . Prof George Follows will be breaking from BSH today to provide an excellent summary overview of CLL first-line treatments for patient's, as well as what is on the horizon. this will be followed with a Q&A discussion between the webinar guest panel.

You can register here: healthunlocked.com/api/redi...

Prof George Follows